Top 10 Anti-Cancer Drugs in India (2026): A Patient and Caregiver Guide
Written by Dr. Hemant Kadam, BAMS | Medically reviewed by Dr. Farah Zariwala, BHMS | Published and last updated: 16 November 2026
Please note: This guide is educational. It describes commonly used cancer medicines. It does not recommend any drug or dose. Your oncologist decides your treatment.
India was projected to see about 15.6 lakh new cancer cases in 2024, according to a 2025 ICMR study in JAMA Network Open. The same study puts a person's lifetime risk of developing cancer in India at 11%. Behind these numbers are families asking one question. Which medicines do oncologists use, and what do they cost? This guide to the top 10 anti-cancer drugs in India answers that question in plain language.
A diagnosis brings a flood of unfamiliar names. Imatinib, trastuzumab, pembrolizumab. Brand names differ from generic names. Prices vary between brands and hospitals. A search for the "best cancer medicine in India" returns confusing, often commercial answers. The truth is simpler: no single medicine is best for everyone.
In this guide, you will discover how the main cancer medicine types work, ten widely used anti-cancer drugs, and what changed in drug prices in 2026, without medical jargon.
Dr. Hemant Kadam (BAMS) wrote this guide. Dr. Farah Zariwala (BHMS), who has more than 10 years of experience in Ayurveda and Homeopathy, reviewed it. Neither replaces your oncologist. Health Reactive, established in 1996, has supported over 1,00,000 patients with Ayurvedic supportive care.
What Are the Main Cancer Medicine Types, and How Do They Work?
Oncologists choose from several cancer medicine types. Each type attacks cancer in a different way. Knowing the type helps you understand side effects, treatment timing and cost. Roswell Park Comprehensive Cancer Center says most modern cancer drugs fall into chemotherapy, targeted therapy and immunotherapy. Hormonal therapy forms a fourth group, used mainly in hormone-sensitive breast and prostate cancers.
Quick answer: Cancer medicines fall into four main types: chemotherapy, targeted therapy, hormonal therapy and immunotherapy. Chemotherapy stops fast-dividing cells from multiplying. Targeted drugs block specific molecules that drive tumour growth. Hormonal drugs lower the hormone signals that feed some tumours. Immunotherapy helps the immune system recognise cancer cells.

|
Medicine type |
How it works |
Examples in this guide |
|
Chemotherapy |
Stops fast-dividing cells from growing and multiplying |
Capecitabine, paclitaxel, cisplatin, carboplatin |
|
Targeted therapy: small molecules |
Enter cancer cells and block proteins that tell them to grow |
Imatinib, palbociclib |
|
Targeted therapy: monoclonal antibodies |
Lab-made proteins that attach to specific targets on or around cancer cells |
Trastuzumab, rituximab, bevacizumab |
|
Hormonal therapy |
Lowers or blocks hormone signals that feed some tumours |
Letrozole |
|
Immunotherapy |
Helps the immune system find and attack cancer cells |
Nivolumab, pembrolizumab |
The American Cancer Society explains that targeted therapies split into small-molecule drugs and monoclonal antibodies. Generic names of small-molecule drugs often end in "-ib", such as imatinib. Monoclonal antibody names usually end in "-mab", such as trastuzumab.
Where do supportive medicines fit?
Not every cancer medicine attacks the tumour. Some prevent or ease side effects. For example, pegfilgrastim helps prevent neutropenia, a fall in infection-fighting white blood cells. It is among the 137 drugs covered by India's 2026 price-margin cap. Anti-nausea medicines, pain relief and nutrition support also form part of good cancer care.
Why does cancer medicine choice vary from patient to patient?
Your oncologist weighs the cancer type, its stage and the results of biomarker tests. Age, other illnesses and earlier treatment also matter. Many regimens combine two or more drugs. That is why a list of "best" drugs can mislead. A drug that suits one patient may be wrong for another.
Which Are the Top 10 Anti-Cancer Drugs Used in India?
We chose ten widely used medicines that cover India's most common cancers and every medicine type above. This is an editorial selection, not a ranking of effectiveness. ICMR data show breast cancer led among women with 238,085 cases, followed by cervical (78,499) and ovarian cancer (48,984). Among men, the oral cavity and pharynx accounted for an estimated 217,327 cases.
Quick answer: Ten widely used anti-cancer drugs in India are imatinib, trastuzumab, capecitabine, letrozole, rituximab, paclitaxel, cisplatin or carboplatin, bevacizumab, palbociclib, and PD-1 immunotherapies such as nivolumab and pembrolizumab. Oncologists prescribe each for specific cancers only. No single drug suits every patient.
|
# |
Drug |
Type |
Commonly prescribed for |
Form |
|
1 |
Imatinib |
Targeted therapy (small molecule) |
Chronic myeloid leukaemia (CML); gastrointestinal stromal tumours (GIST) |
Oral tablet |
|
2 |
Trastuzumab |
Targeted therapy (monoclonal antibody) |
HER2-positive breast cancer; some stomach cancers |
Infusion |
|
3 |
Capecitabine |
Chemotherapy |
Colorectal and breast cancers |
Oral tablet |
|
4 |
Letrozole |
Hormonal therapy |
Hormone-receptor-positive breast cancer |
Oral tablet |
|
5 |
Rituximab |
Targeted therapy (anti-CD20 antibody) |
B-cell non-Hodgkin lymphoma; some B-cell leukaemias |
Infusion |
|
6 |
Paclitaxel |
Chemotherapy (taxane) |
Breast, ovarian and lung cancers |
Infusion |
|
7 |
Cisplatin and carboplatin |
Chemotherapy (platinum-based) |
Head and neck, cervical, ovarian and lung cancers |
Infusion |
|
8 |
Bevacizumab |
Targeted therapy (angiogenesis inhibitor) |
Colorectal, lung, ovarian, cervical and brain cancers |
Infusion |
|
9 |
Palbociclib |
Targeted therapy (CDK4/6 inhibitor) |
Advanced hormone-receptor-positive, HER2-negative breast cancer |
Oral capsule or tablet |
|
10 |
Nivolumab and pembrolizumab |
Immunotherapy (PD-1 checkpoint inhibitors) |
Several cancer types, selected by cancer type and biomarker results |
Infusion |
1. Imatinib: a targeted tablet for CML and GIST
What it does. Imatinib blocks BCR-ABL, an abnormal protein that drives chronic myeloid leukaemia (CML). The National Cancer Institute also lists it for gastrointestinal stromal tumours (GIST). Doctors test for the genetic marker before prescribing. Patients usually take it as a daily tablet.
India note. NLEM 2022 lists imatinib as an essential medicine. Drugs on that list fall under NPPA ceiling prices, according to The Tribune.
2. Trastuzumab: a HER2-targeted antibody
What it does. Trastuzumab attaches to HER2, a protein found in high amounts on some cancer cells. The Cancer Council Australia notes that high HER2 levels make cancer cells grow out of control. Doctors prescribe it for HER2-positive breast cancer and some stomach cancers. A tissue test confirms HER2 status first. Nurses give it as an infusion.
India note. NLEM 2022 includes trastuzumab.
3. Capecitabine: an oral chemotherapy
What it does. Capecitabine is a chemotherapy tablet. The body converts it into fluorouracil (5-FU). Doctors prescribe it for colorectal and breast cancers. Patients take it in cycles. Report diarrhoea, mouth sores or red, sore palms early.
India note. Both capecitabine and 5-fluorouracil appear on NLEM 2022.
4. Letrozole: a hormonal tablet for breast cancer
What it does. Letrozole lowers oestrogen levels in the body. Some breast cancers need oestrogen to grow. Doctors prescribe it mainly after menopause for hormone-receptor-positive breast cancer. Patients take it daily, often for years. Joint pain and bone thinning are known effects, so doctors monitor bone health.
India note. NLEM 2022 includes letrozole.
5. Rituximab: an anti-CD20 antibody for lymphoma
What it does. Rituximab targets CD20, a protein on B cells. The Cancer Council Australia lists anti-CD20 antibodies for B-cell leukaemias and non-Hodgkin lymphomas. Doctors often combine rituximab with chemotherapy. Nurses give it by infusion and watch for infusion reactions.
India note. NLEM 2022 includes rituximab.
6. Paclitaxel: a taxane chemotherapy
What it does. Paclitaxel stops cancer cells from completing cell division. Doctors prescribe it for breast, ovarian and lung cancers, often alongside other drugs. Patients receive it by infusion every few weeks. Tingling in hands and feet, hair loss and low blood counts are common effects. Tell your care team about numbness early.
7. Cisplatin and carboplatin: platinum-based chemotherapy
What they do. Platinum drugs damage the DNA of cancer cells so they cannot divide. Doctors use them in head and neck, cervical, ovarian and lung cancers. These matter in India, where oral cavity cancers and cervical cancers are common. Cisplatin can affect the kidneys and hearing. Care teams therefore plan hydration and blood tests around each dose.
8. Bevacizumab: an angiogenesis inhibitor
What it does. Bevacizumab reduces the blood supply to a tumour. The Cancer Council Australia describes this group as angiogenesis inhibitors. Doctors prescribe it in colorectal, lung, ovarian, cervical and brain cancers, usually with chemotherapy.
India note. Bevacizumab is the second-highest-selling anti-neoplastic drug in Indian retail channels, according to Business Standard citing Pharmarack. The Avastin MRP stayed at ₹1.23 lakh per 400 mg vial after the October 2026 revision. Two biosimilar brands, Bevacimab and Bevakalp, fell by 86% and 69%.
9. Palbociclib: a CDK4/6 inhibitor
What it does. Palbociclib blocks CDK4 and CDK6, proteins that push cells to divide. The Cancer Council Australia lists CDK inhibitors as a targeted therapy group. Doctors prescribe it with hormonal therapy for advanced hormone-receptor-positive, HER2-negative breast cancer. Patients take it orally, with regular blood count checks.
India note. Palbopro, a palbociclib brand, fell from ₹40,421.33 to ₹2,720 per unit, a 93.3% cut, in the October 2026 revision, Business Standard reports.
10. Nivolumab and pembrolizumab: PD-1 immunotherapy
What they do. Both drugs block the PD-1 receptor on T cells. This lets the immune system recognise and attack cancer, as CION Cancer Clinics explains. Pembrolizumab (Keytruda) is indicated for more than 21 cancer types, says Business Standard. Biomarker results and cancer type decide who qualifies. Immunotherapy can cause immune-related side effects, so patients need close follow-up.
India note. Nivolumab MRPs did not change in the 2026 revision, and Keytruda stays at ₹2.16 lakh. Separately, Zydus Lifesciences launched a nivolumab biosimilar in January 2026, about 75% cheaper according to its launch coverage. Ask your oncologist whether an approved biosimilar suits your plan.
How are these drugs given, and how long does treatment last?
Oral drugs, such as imatinib, capecitabine, letrozole and palbociclib, are taken at home on a set schedule. Infusion drugs, such as trastuzumab, paclitaxel, bevacizumab and the immunotherapies, are given at a hospital or day care centre. Each visit may take a few hours, including tests and monitoring.
Duration depends on the drug and the cancer. Some regimens run in cycles of three or four weeks for several months. Hormonal tablets such as letrozole can continue for years. Some targeted tablets continue for as long as they work and are tolerated. Your oncologist reviews scans and blood tests regularly and adjusts the plan.
Missing doses or stopping early can reduce a drug's benefit. If side effects feel unmanageable, call your care team before you change anything. They can often adjust the dose, add supportive medicines or change the schedule.
What side effects should you expect from these medicine types?
Side effects differ by medicine type, drug and dose. The table gives a general overview only. Your care team will explain what to expect with your own regimen. Report fever, severe vomiting, bleeding, breathlessness or sudden swelling immediately, without waiting for your next appointment.
|
Medicine type |
Effects people commonly report |
Why it happens |
|
Chemotherapy |
Nausea, tiredness, hair loss, mouth sores, low blood counts, higher infection risk |
Drugs also affect healthy fast-dividing cells, such as hair roots and bone marrow |
|
Targeted therapy |
Skin rash, diarrhoea, blood pressure changes, liver test changes, infusion reactions |
Drugs block signals that some healthy cells also use |
|
Hormonal therapy |
Hot flushes, joint pain, bone thinning, mood changes |
Drugs lower hormone levels the body normally uses |
|
Immunotherapy |
Tiredness, skin rash, diarrhoea, thyroid changes, rarely inflamed lungs or bowel |
A more active immune system can also attack healthy tissue |
Many side effects can be managed if you report them early. Keep a simple diary of symptoms, dates and the medicines you took. Show it at every visit. Ask whether supportive medicines, diet changes or physiotherapy can help.
Caregivers play a key role here. They notice changes in appetite, sleep and mood that patients may overlook. Agree on a short list of warning signs with your oncologist so that everyone at home knows when to call.
How Much Do Cancer Medicines Cost in India, and What Changed in 2026?
Cancer drug prices in India have long depended on trade margins as much as manufacturing cost. In 2026, the government acted at scale. Understanding the change helps you ask better questions about the price on your bill.
Quick answer: In October 2026, India's drug pricing authority capped trade margins at 30% of MRP for 137 non-scheduled anti-cancer drugs. The cap took effect on 9 November 2026. The government expects retail prices to fall by up to 70%. Revised MRPs for 543 brands already show cuts of up to 93%.

NPPA announced the 137-drug exercise on 17 October 2026. Moneylife reports it took effect on 9 November 2026. The covered drugs include immunotherapy drugs, denosumab and pegfilgrastim. Business Standard reported on 28 October that NPPA revised MRPs for 543 brands and pack sizes.
How did India get here?
- 2019 pilot. NPPA capped trade margins on 42 non-scheduled anti-cancer drugs at 30%. MRPs fell by up to 90% across 526 brands.
- NPPA's own analysis. The average trade mark-up on non-scheduled anti-cancer drugs was about 170%, reaching up to 700% in some cases, according to The Tribune.
- NLEM 2022. The essential medicines list added four anti-cancer drugs: bendamustine, irinotecan, lenalidomide and leuprolide, per Business Today.
- October 2026. The 137-drug margin cap extended the 2019 approach to a much wider list.
Why have some prices not fallen?
The October 2026 revision cut generics and biosimilars sharply but left several innovator brands unchanged. The table below shows the pattern, based on Business Standard's report.
|
Medicine and brand |
MRP after October 2026 revision |
Change |
|
Palbociclib (Palbopro) |
₹2,720 per unit (was ₹40,421.33) |
Down 93.3% |
|
Bevacizumab biosimilar (Bevacimab, Abbott) |
Revised (new MRP not listed in report) |
Down 86% |
|
Bevacizumab biosimilar (Bevakalp, Torrent) |
Revised (new MRP not listed in report) |
Down 69% |
|
Bevacizumab originator (Avastin) |
₹1.23 lakh per 400 mg vial |
Unchanged |
|
Pembrolizumab (Keytruda) |
₹2.16 lakh |
Unchanged |
|
Nivolumab (BMS India, Dr Reddy's) |
No change in MRP |
Unchanged |
Oncologist Sandeep Nayak of KIMS Hospital, Bengaluru, told Business Standard that unchanged innovator prices suggest their margins may already have been reasonable. Patient groups disagree. The All India Drug Action Network argues that manufacturer patient assistance programmes, which offer free or discounted medicines, weakened the calculated price cuts. The actual saving for you depends on your brand, your regimen and whether your hospital passes on the revised price.
Our perspective: The 2026 reforms help most where generics and biosimilars compete. They help least where one patented brand dominates. When you discuss cost, ask your oncologist whether an approved generic or biosimilar exists for your prescribed molecule.
Generic, brand and biosimilar: what is the difference?
A generic medicine contains the same active ingredient as a brand-name drug. Generics usually apply to chemical drugs, such as capecitabine or imatinib. A biosimilar is the equivalent for biologic medicines, such as trastuzumab or bevacizumab. Biologics come from living cells, so copies are "highly similar" rather than identical. Regulators review the evidence before approval.
Neither word tells you about quality on its own. What matters is the manufacturer's licence, the approval status and your oncologist's judgement. Never swap brands on your own. Ask your oncologist or hospital pharmacist first, because dose forms, pack sizes and infusion protocols can differ between brands.
How Do You Find Cancer Medicine Near Me Safely?
Searching for cancer medicine near me often leads to unverified sellers. Cancer drugs are high-value, temperature-sensitive and sometimes counterfeited. A safe supply chain protects both your health and your wallet.
Quick answer: Buy cancer medicines only on an oncologist's written prescription from a licensed pharmacy or your treating hospital's pharmacy. Check the seal, batch number, expiry date and MRP on every pack. Ask for a printed bill. Never buy from unverified online sellers or accept unsealed, repacked or unlabelled medicines.
A seven-step safety checklist
- Get a written prescription that names the generic drug, brand, dose and schedule.
- Use your treating hospital's pharmacy or a licensed chemist you can identify.
- Check the seal, batch number, expiry date and printed MRP on every pack.
- Compare the brand's MRP with the revised price. NPPA says it will update the list periodically.
- Ask the hospital about patient assistance programmes. These are manufacturer-funded schemes offering free or discounted medicines to eligible patients.
- Ask about insurance and cashless options before treatment starts, not after.
- Keep every bill and report unusual reactions to your care team the same day.
What about care closer to home?
The Health Ministry has approved more than 200 Day Care Cancer Centres for 2025–26 to upgrade cancer care in rural areas, according to Rising Kashmir. The Ministry has also started a national screening programme for oral, breast and cervical cancers. Ask your district hospital whether these services are available near you.
Warning signs of an unsafe seller
- No prescription asked, or no bill issued.
- Unsealed, repacked or unlabelled strips and vials.
- Offers through social media or messaging apps only.
- Claims of a "miracle", "guaranteed" or "secret" cancer cure.
Health Reactive does not sell prescription cancer drugs. We offer Ayurvedic supportive care alongside the treatment your oncologist prescribes.
What Should You Ask Your Oncologist About Anti-Cancer Drugs?
Good questions turn a rushed appointment into a clear plan. Write them down before you go. Bring a family member to take notes. Ask the oncologist to explain any term you do not understand.
Quick answer: Ask your oncologist which medicine type you will receive, why it suits your cancer, and which biomarker tests are needed. Ask about side effects, total cost, and whether an approved generic or biosimilar exists. Also tell your oncologist about every supplement and herbal product you take.
- Which type of medicine is this: chemotherapy, targeted, hormonal or immunotherapy?
- Why is this drug right for my cancer type and stage?
- Do I need a biomarker test, such as HER2 or BCR-ABL, before starting?
- How will I take it, how often, and for how long?
- Which side effects should I report the same day?
- What will the full course cost, including tests, hospital stay and supportive medicines?
- Is an approved generic or biosimilar suitable for me?
- Does the hospital offer a patient assistance programme for this drug?
- Are there foods, medicines or herbal products I should avoid?
- Who do I call if I feel unwell outside clinic hours?
For a longer preparation list, read our guide on questions to ask before chemotherapy (link to be added).
Should you ask for a second opinion?
A second opinion is a normal part of cancer care. Ask for one when the diagnosis is rare, when treatment options differ between doctors, or when you simply want reassurance. Request copies of your pathology report, scans and prescriptions first. Most oncologists welcome the request. A second opinion can confirm the plan or refine the choice of medicine, and it rarely delays care by more than a few days.
How Can Ayurvedic Supportive Care Fit Alongside Cancer Medicines?
Many patients and caregivers ask about Ayurveda during cancer treatment. The honest answer has two parts. Ayurveda cannot treat cancer. It may offer supportive care for how you feel during treatment, and only when your oncologist knows about it.
Quick answer: Ayurvedic supportive care aims to help people feel better during conventional cancer treatment. It does not replace chemotherapy, targeted therapy, immunotherapy or surgery. Patients should tell their oncologist about every herbal product. Health Reactive's Body Revival is a complementary supportive-care formulation, not a cancer treatment.

Health Reactive is an ISO/GMP-certified, AYUSH-registered Ayurvedic manufacturer established in 1996. Its flagship product, Body Revival, is a nine-herb Ayurvedic liquid formulation positioned as complementary supportive care alongside conventional treatment.
What the CTRI-registered study did and did not show
Body Revival was studied in a 44-patient, 12-week, open-label study at J.B. Roy State Ayurvedic Medical College & Hospital, Kolkata. The study is registered with the Clinical Trials Registry – India as CTRI/2023/11/059465. It completed in November 2024. Three limits matter. It enrolled post-surgical patients only. It had no control group because it was open-label. It has not yet been peer-reviewed. Do not read it as evidence for any other condition, or as proof that Body Revival treats cancer.
Four safety rules for herbal products during cancer treatment
- Tell your oncologist first. Some herbal products can interact with cancer medicines or change how your body handles them.
- Never delay or stop prescribed treatment. Supportive care sits alongside your treatment plan, not in place of it.
- Avoid any product that promises a cure. Credible supportive-care providers do not make that claim.
- Check credentials. Look for manufacturing certifications and registration, and ask for the ingredient list.
Read our related guide, Ayurveda with chemotherapy: safety first, before starting any herbal product.
Frequently Asked Questions
The main types are chemotherapy, targeted therapy, hormonal therapy and immunotherapy. Chemotherapy stops fast-dividing cells from multiplying. Targeted drugs block specific molecules that drive tumour growth. Hormonal drugs lower hormone signals that feed some tumours. Immunotherapy helps the immune system find cancer cells.
No single medicine is best for everyone. The right drug depends on the cancer type, stage, biomarker test results, age and other health conditions. Your oncologist chooses it. Be cautious of any website or seller that names one best cancer medicine.
Many are. In October 2026, India capped trade margins at 30 percent of MRP for 137 non-scheduled anti-cancer drugs, effective 9 November 2026. Some generic and biosimilar brands fell by up to 93 percent. Several innovator brands, such as Keytruda, kept their earlier MRP.
No. Ayurvedic products do not cure cancer and must never replace treatment prescribed by an oncologist. Ayurvedic supportive care aims to help people feel better during conventional treatment. Always tell your oncologist about every herbal product you take.
Buy cancer medicines on a written prescription from your treating hospital's pharmacy or a licensed chemist. Check the seal, batch number, expiry date and MRP, and keep a printed bill. Avoid unverified online sellers and social media offers.
A biosimilar is a biologic medicine approved as highly similar to an original biologic. Indian biosimilars need approval from the drug regulator before sale. Your oncologist decides whether a biosimilar suits your treatment plan.
Chemotherapy attacks cells that divide quickly, including some healthy cells. Targeted therapy blocks specific molecules that cancer cells rely on to grow. Targeted drugs often need a biomarker test first. Doctors sometimes combine both types in one treatment plan.
Only after discussing it with your oncologist. Some herbal products can interact with cancer medicines or affect how your body handles them. Never stop or delay prescribed treatment to try a herbal product.
Cancer medicines fall into four main types, and each of the top 10 anti cancer drugs in India works in a different way. No single drug is best for everyone, so treat any "best cancer medicine in India" claim with caution. The 2026 price-margin cap has made many medicines cheaper, but innovator brands such as Keytruda and Avastin have not changed. Buy only from licensed sources and ask your oncologist about generics and biosimilars. Supportive care can sit alongside treatment, but it never replaces it.
Next step: Book a free supportive-care consultation with Health Reactive. Call +91-86553-10500 or visit healthreactive.co/bodyrevival. Our address: Excellency Building, Commercial Wing, 1st Floor, Opp. MTNL, Mhada Road, Four Bungalows, Andheri West, Mumbai 400053.
About the author and reviewer
Dr. Hemant Kadam, BAMS, is the author of this guide.
Dr. Farah Zariwala, BHMS, is the medical reviewer. She has more than 10 years of experience in Ayurveda and Homeopathy.